Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Pharmacoeconomics|May 23, 2014
Cost-effectiveness analysis of interventions for tuberculosis control: DALYs versus QALYsR Diel, N LampeniusRespiratory Medicine|December 3, 2014
Cost of multi drug resistance tuberculosis in GermanyR Diel, A Nienhaus, N Lampenius, et al.Pneumologie (Stuttgart, Germany)|May 14, 2015
[Current Issues Arising from Tuberculosis Screening with Interferon-Gamma-Release Assays (IGRAs)]R Diel, A NienhausDeutsche Medizinische Wochenschrift (1946)|September 16, 1988
[Primary amyloidosis as a rare cause of acute liver insufficiency]R Diel, C KrügerUltraschall in Der Medizin (Stuttgart, Germany : 1980)|December 1, 1991
[Acute abdomen in hemorrhage into a twisted pedicled ectopic second spleen in the right mesogastrum]R Diel, V HamborgThe International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 18, 2003
Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001R Diel, S NiemannEuropean Journal of Epidemiology|October 16, 2001
Transmission of hepatitis A in hamburg, germany, 1998-1999--A prospective population based studyR Diel, S SchneiderBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 29, 2005
[Contribution of the Public Health Service to cost of illness studies]R Diel, T ForsterPulmonology|July 28, 2021
Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysisR Diel, A NienhausPneumologie (Stuttgart, Germany)|September 10, 2010
[Tuberculosis - historical development, current status, future prospects]R Loddenkemper, R Diel, T SchabergPageof 5